Insight into the role of TXNRD2 in steroidogenesis through a novel homozygous TXNRD2 splice variant.

Brachet, Cécile; Laemmle, Alexander; Cools, Martine; Sauter, Kay-Sara; De Baere, Elfride; Vanlander, Arnaud; Pandey, Amit V; Du Toit, Therina; Voegel, Clarissa D; Heinrichs, Claudine; Verdin, Hannah; Flück, Christa E (2024). Insight into the role of TXNRD2 in steroidogenesis through a novel homozygous TXNRD2 splice variant. European journal of endocrinology, 191(2), pp. 144-155. Oxford Academic 10.1093/ejendo/lvae090

[img]
Preview
Text
lvae090.pdf - Accepted Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

OBJECTIVE

Adrenal cortisol production occurs through a biosynthetic pathway which depend on NADH and NADPH for energy supply. The mitochondrial respiratory chain and the reactive oxygen species (ROS) detoxification system are therefore important for steroidogenesis. Mitochondrial dysfunction leading to oxidative stress has been implicated in the pathogenesis of several adrenal conditions. Nonetheless, only very few patients with variants in one gene of the ROS detoxification system, Thioredoxin Reductase 2 (TXNRD2), have been described with variable phenotypes.

DESIGN

Clinical, genetic, structural and functional characterization of a novel, bi-allelic TXNRD2 splice variant.

METHODS

On human biomaterial, we performed whole exome sequencing to identify and RNA analysis to characterize the specific TXNRD2 splice variant. Amino acid conservation analysis and protein structure modeling were performed in silico. Using patient's fibroblast-derived human induced pluripotent stem cells, we generated adrenal-like cells (iALC) to study the impact of wild-type (WT) and mutant TXNRD2 on adrenal steroidogenesis and ROS production.

RESULTS

The patient had a complex phenotype of primary adrenal insufficiency (PAI), combined with genital, ophthalmological and neurological features. He carried a homozygous splice variant c.1348-1G>T in TXNRD2 which leads to a shorter protein lacking the C-terminus and thereby affecting homodimerization and FAD binding. Patient-derived iALC showed loss of cortisol production with overall diminished adrenal steroidogenesis, while ROS production was significantly increased.

CONCLUSION

Lack of TXNRD2 activity for mitochondrial ROS detoxification affects adrenal steroidogenesis and predominantly cortisol production.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Nephrology and Hypertension
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine > Endocrinology/Metabolic Disorders
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Forschungsgruppe Endokrinologie / Diabetologie / Metabolik (Pädiatrie)

UniBE Contributor:

Lämmle, Alexander, Sauter, Kay Sara, Pandey, Amit Vikram, Du Toit, Therina (A), Vögel, Clarissa, Flück Pandey, Christa Emma

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0804-4643

Publisher:

Oxford Academic

Language:

English

Submitter:

Pubmed Import

Date Deposited:

05 Aug 2024 09:43

Last Modified:

09 Aug 2024 00:16

Publisher DOI:

10.1093/ejendo/lvae090

PubMed ID:

39097530

Uncontrolled Keywords:

TXNRD2 gonadal insufficiency mitochondrial reactive oxygen species primary adrenal insufficiency steroidogenesis

BORIS DOI:

10.48350/199474

URI:

https://boris.unibe.ch/id/eprint/199474

Actions (login required)

Edit item Edit item
Provide Feedback